Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790386 | Urologic Oncology: Seminars and Original Investigations | 2017 | 13 Pages |
Abstract
Our results demonstrate that the CAM assay is a useful tool for studying tumor growth and response to conventional anticancer drugs under 3D conditions, especially cytotoxic drugs as cisplatin. With some limitations, it might serve as a cost- and time-effective preclinical screening assay for novel therapeutic approaches before further assessment in expensive and cumbersome animal models.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Margaretha A. M.Sc., Anuja M.D., Ph.D., Andrea Ph.D., Michèle J. Ph.D., Wolfgang A. Ph.D., Gommert A. M.D., Peter M.D., Roman Ph.D., Günter M.D.,